In vitro platelet binding compared with in vivo thrombus imaging using α(IIb)β3-targeted radioligands

Thrombosis and Haemostasis

Volumn 80, Issue 5, 1998, Pages 845-851

  Knight, Linda C ^a,b   Romano, Jan E ^a   Maurer, Alan H ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; BARBOURIN; BITISTATIN; DISINTEGRIN; FIBRINOGEN; INTEGRIN; IODINE 123; IODINE 125; KISTRIN; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOAVAILABILITY; CELL STIMULATION; CONTROLLED STUDY; DEIODINATION; DIAGNOSTIC IMAGING; DISSOCIATION; HALF LIFE TIME; IMAGE QUALITY; LUNG EMBOLISM; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBUS; VEIN THROMBOSIS;

EID: 0031774394     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615369     Document Type: Article

References (33)

1. Carter C, Gent M, Leclerc JR. The epidemiology of venous thrombosis. In: Hemostasis and Thrombosis. Basic principles and clinical practice. 2nd ed. Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Philadelphia: J B Lippincott 1987; 1185-98.
2. PIOPED. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263: 2753-9.
3. Hirsh J, Marder VJ, Salzman EW, Hull RD. Treatment of venous thromboembolism. In: Hemostasis and Thrombosis. Basic principles and clinical practice. 2nd ed. Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Philadelphia: J B Lippincott 1987; 1266-72.
4. Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393-401.
5. Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GPIIb/IIa receptor number by quantification of 7E3 binding to human platelets. Blood 1996; 88: 907-14.
6. Coller BS. A new murine monoclonal antibody reports an activationdependent change in the conformation and/or microenvironment of platelet GPiIb/IIIa complex. J Clin Invest 1985; 76; 101-8.
7. Bai Y, Durbin H, Hogg N. Monoclonal antibodies specific for platelet glycoproteins react with human monocytes. Blood 1984; 64: 139-46.
8. Peters AM, Lavender JP, Needham SG, Loutfi I, Snook D, Epenetos AA, Lumley P, Keery RJ, Hogg N. Imaging thrombus with radiolabelled monoclonal antibody to platelets. Brit Med J 1986; 293: 1525-7.
9. Oster ZH, Srivastava SC, Som P, Meinken GE, Scudder LE, Yamamoto K, Atkins HL, Brill AB, Coller BS. Thrombus radioimmunoscintigraphy: An approach using monoclonal antiplatelet antibody. Proc Natl Acad Sci USA 1985; 82: 3465-3468.
10. Knight LC, Radcliffe R, Maurer AH, Rodwell JD, Alvarez VL. Thrombus imaging with technetium-99m synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets. J Nucl Med 1994; 35: 282-8.
11. Lister-James J, Knight LC, Maurer AH, Bush LR, Moyer BR, Dean RT. Thrombus imaging with a technetium-99m-labeled, activated platelet receptor-binding peptide. J Nucl Med 1996; 37: 775-81.
12. Dennis MS, Henzel WJ, Pitti RM, Lipari MT, Napier MA, Deisher TA, Bunting S, Lazarus RA. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: Evidence for a family of platelet-aggregation inhibitors. Proc Natl Acad Sci USA 1990; 87: 2471-5.
13. Gould RJ, Polokoff MA, Friedman PA, Huang T-F, Holt JC, Cook JJ, Niewiarowski S. Disintegrins: A family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 1990; 195: 168-71.
14. Scarborough RM, Rose JW, Hsu MA, Phillips DR, Fried VA, Campbell AM, Nannizzi L, Charo IF. Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J Biol Chem 1991; 266: 9359-62.
15. Shebuski RJ, Stabilito IJ, Sitko GR, Polokoff MH. Acceleration of recombinant tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by the combination of heparin and the Arg-Gly-Asp-containing peptide bitistatin in a canine model of coronary thrombosis. Circulation 1990; 82: 169-77.
16. Yasuda T, Gold HK, Leinbach RC, Yaoita H, Fallon JT, Guerrero L, Napier MA, Bunting S, Collen D. Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation. Circulation 1991; 83: 1038-47.
17. Bernabei A, Gikakis N, Kowalska MA, Niewiarowski S, Edmunds LH. Iloprost and echistatin protect platelets during simulated extracorporeal circulation. Ann Thorac Surg 1995; 59: 149-53.
18. Knight LC, Maurer AH, Romano JE. Comparison of Iodine-123-disintegrins for imaging thrombi and emboli in a canine model. J Nucl Med 1996; 37: 476-82.
19. Shebuski RJ, Ramjit DR, Bencen GH, Polokoff MA. Characterization and platelet inhibitory activity of bitistatin, a potent arginine-glycine-aspartic acid-containing peptide from the venom of the viper Bitis arietans. J Biol Chem 1989; 264: 21550-6.
20. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3α, 6α-diphenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849-857.
21. Parker RC, Methods of Tissue Culture. 3rd ed. New York: Hoeber Medical Division, Harper and Row; 1962.
22. Burt DR. Receptor Binding Methodology and Analysis. In: Receptor Binding in Drug Research. R.A. O'Brien, eds. New York: Marcel Dekker 1986; 4-29.
23. 99mTc-Antifibrin Fab' fragments for imaging venous thrombi: Evaluation in a canine model. Radiology 1989; 173: 163-9.
24. Knight LC. Scintigraphic methods for detecting vascular thrombus. J Nucl Med 1993; 34: 554-61.
25. McLane MA, Kowalska MA, Silver L, Shattil SJ, Niewiarowski S. Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets. Biochemical Journal 1994; 301: 429-36.
26. Scheffel U, Tsan M-F, Mitchell TG, Camargo EE, Braine H, Ezekowitz MD, Nickoloff EL, Hill-Zobel R, Mclntyre PA. Human platelets labeled with In-111 8-hyuroxyquinoline: Kinetics, distribution, and estimates of radiation dose. J Nucl Med 1982; 23: 149-56.
27. Calvete JJ. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex. Thromb Haemost 1994; 72: 1-15.
28. 99Tc monoclonal antifibrin antibody. Circulation 1992; 85: 298-304.
29. Knight LC, Maurer AH, Ammar IA, Shealy DJ, Mattis JA. Evaluation of 111In-labeled anti-fibrin antibody for imaging vascular thrombi. J Nucl Med 1988; 29: 494-502.
30. deFaucal P, Peltier P, Planchon B, Dupas B, Touze M-D, Baron D, Schaible T, Berger HJ, Chatal J-F. Evaluation of 111In-labeled antifibrin monoclonal antibody for the diagnosis of venous thrombotic disease. J Nucl Med 1991; 32: 785-91.
31. Muto P, Lastoria S, Varrella P, Vergara E, Salvatore M, Morgano G, Lister-James J, Bernardy JD, Dean RT, Wencker D, Borer JS. Detecting deep venous thrombosis with technetium-99m-labeled synthetic peptide P280. J Nucl Med 1995; 36: 1384-91.
32. DeNardo SJ, DeNardo GL. Iodine-123 fibrinogen scintigraphy. Semin Nucl Med 1977; 7: 245-51.
33. 99mTc hexamethylpropyleneamineoxime (HMPAO) as a platelet label: evaluation of labelling parameters and first in vivo results. Nuclear Medicine Communications 1988; 9: 831-42.